Navigation Links
AMDL, Inc.'s President & CEO Mr. Gary Dreher Retires
Date:11/4/2008

TUSTIN, Calif., Nov. 4 /PRNewswire-FirstCall/ -- (http://www.amdl.com) AMDL, Inc. (Amex: ADL), announced today its President, Chief Executive Officer and Director, Gary L. Dreher, has retired at the close of business October 31, 2008. Mr. Dreher has been a member of the Company's leadership team and a director for many years. The Company extends its best wishes to Mr. Dreher on his retirement.

About AMDL:

Headquartered in Tustin, CA with operations in Shenzhen, Jiangxi, and Jilin, China, AMDL, Inc., along with its subsidiary Jade Pharmaceutical Inc. (JPI), is a vertically integrated bio-pharmaceutical company devoted to the research, development, manufacturing, and marketing of diagnostic, pharmaceutical, nutritional supplement, and cosmetic products. The company employs approximately 320 people in the U.S. and China. The Company has an additional 4 pharmaceutical and diagnostic products under review by various regulatory authorities.

Forward Looking Statements:

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this document include certain predictions and projections that may be considered forward- looking statements under securities law. These statements involve a number of important risks and uncertainties that could cause actual results to differ materially including, but not limited to, the performance of joint venture partners, as well as other economic, competitive and technological factors involving the Company's operations, markets, services, products, and prices. With respect to AMDL Inc., except for the historical information contained herein, the matters discussed in this document are forward-looking statements involving risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. Potential risks and uncertainties related to the Company's access to additional capital, competition and dependence on key management.

AMDL Contact:

Kristine Szarkowitz

Director-Investor Relations

kszarkowitz@amdl.com

(M) (206) 310-5323


'/>"/>
SOURCE AMDL, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. AMDL, Inc. Named to Deloitte LLC Technology Fast 50
2. AMDL, Inc. Announces Strategic Realignment
3. AMDL, Inc. to Present at Maxim Group Growth Conference October 7, 2008
4. AMDL, Inc. Closes Private Placement of Convertible Notes
5. The Wall Street Transcript Interviews AMDL, Inc. CEO & President Gary Dreher for Fall Healthcare Issue
6. Rudd Report Highlights AMDL, Inc.s Latest Business Achievements; Supports 2008 Financial Guidance
7. AMDL, Inc. Retains Strategic Growth International Inc. as its Global Investor Relations Advisor
8. VNUS Medical Technologies, Inc. Announces the Hiring of Guido Smeets, MD, as Vice President of Clinical Research and Chief Medical Officer
9. Sharps Compliance Corp. Announces Appointment of John R. Grow as President and Chief Operating Officer
10. Nutrition 21 Appoints Pam McWilliams, Vice President - General Manager of Direct Response
11. Boston Healthcare Appoints Adam Barak as Vice President Enhancing Its International Pricing and Reimbursement Capability
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... 29, 2017 WuXi Biologics, a leading ... to biologics and a WuXi AppTec Affiliate, today ... Best Bioprocessing Excellence Award from IMAPAC, a leading ... aims to recognize outstanding leaders and trend-setters of ... bioprocessing and biomanufacturing experts in the industry, along ...
(Date:3/29/2017)... 2017  Applied BioMath ( www.appliedbiomath.com ), ... drug research and development, today announced an ... for quantitative systems pharmacology (QSP) support for ... treatment of cancer. Applied ... toxicology studies and first-in-human dose predictions for ...
(Date:3/29/2017)... ... 29, 2017 , ... Cancer diagnostics and pathology workflow solution ... the Association of Community Cancer Centers (ACCC) 43rd Annual Meeting, CANCERSCAPE ... key stakeholders from leading national organizations to share insights on how value-based care, ...
(Date:3/29/2017)... COLUMBIA, MO , March 29, 2017 /PRNewswire/ - ... and its partners Nordion, a business of Sterigenics International, ... Request (LAR) has been submitted to the U.S. Nuclear ... implementing domestic U.S. production of molybdenum-99 (Mo-99). Once operational, ... nearly half of U.S. demand for Mo-99, which currently ...
Breaking Biology Technology:
(Date:3/20/2017)... HANOVER, Germany , March 20, 2017 At ... Hamburg -based biometrics manufacturer DERMALOG. The Chancellor came to the ... Japan is this year,s CeBIT partner country. At the largest ... important biometrics in use: fingerprint, face and iris recognition as well as ... ...
(Date:3/9/2017)... MOUNTAIN VIEW, Calif. , March 9, ... Simple," and 23andMe , the leading personal genetics ... choices.  Zipongo can now provide customers with personalized nutrition ... goals and biometrics, but also genetic markers impacting how ... Zipongo,s personalized food decision support platform uses biometrics ...
(Date:3/2/2017)... March 2, 2017 Summary This ... understand Merck KGaA and its partnering interests and activities ... Description The Partnering Deals and Alliance since ... activity of one of the world,s leading life sciences ... upon purchase to ensure inclusion of the most up ...
Breaking Biology News(10 mins):